Clinical trial
REPAIR-AMI: Intracoronary Progenitor Cells in Acute Myocardial Infarction (AMI)
NCT00279175 · A. M. Zeiher, Other · Completed
Key facts
| NCT number | NCT00279175 |
|---|---|
| Title | REPAIR-AMI: Intracoronary Progenitor Cells in Acute Myocardial Infarction (AMI) |
| Official title | Reinfusion of Enriched Progenitor Cells And Infarct Remodeling in Acute Myocardial Infarction (REPAIR - AMI) |
| Lead sponsor | A. M. Zeiher, Other |
| Collaborators | Johann Wolfgang Goethe University Hospital Blutspendedienst Baden-Württemberg - Hessen Guidant Corporation Industry Eli Lilly and Company |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Biological |
| Interventions | Intracoronary infusion of enriched bone marrow-derived progenitor cells, Placebo medium supplemented with autologous serum |
| Enrollment | 204 |
| Start date | Apr 1, 2004 |
| Primary completion | Oct 1, 2005 |
| Completion | Dec 1, 2010 |
| First posted | Jan 19, 2006 |
| Last update posted | Sep 20, 2012 |
| Countries | Germany, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: